Pages that link to "Q36612475"
Jump to navigation
Jump to search
The following pages link to High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up (Q36612475):
Displaying 50 items.
- HPV and Cervical Cancer: Updates on an Established Relationship (Q22305479) (← links)
- Role of human papillomaviruses in carcinogenesis (Q22305628) (← links)
- Randomized controlled trials of interventions to prevent sexually transmitted infections: learning from the past to plan for the future (Q24600011) (← links)
- Role of the microbiome in non-gastrointestinal cancers (Q26747710) (← links)
- Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline (Q26749285) (← links)
- Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV (Q26783973) (← links)
- The "HPV Discussion": Effective Use of Data to Deliver Recommendations to Patients Impacted by HPV (Q26798297) (← links)
- Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus (Q26799574) (← links)
- Lessons learned from next-generation sequencing in head and neck cancer (Q27009209) (← links)
- Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins (Q27013018) (← links)
- Safety of human papillomavirus vaccines: a review (Q28082119) (← links)
- Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines (Q28246307) (← links)
- Prevention strategies against the human papillomavirus: the effectiveness of vaccination (Q28253369) (← links)
- The human papillomavirus vaccine in Canada (Q28278978) (← links)
- Capsomer vaccines protect mice from vaginal challenge with human papillomavirus (Q28743261) (← links)
- Correlating immunity with protection for HPV infection (Q30051687) (← links)
- HPV vaccines - A review of the first decade (Q30234669) (← links)
- Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada (Q30573204) (← links)
- Knowledge, attitude, practice and barriers on vaccination against human papillomavirus infection: a cross-sectional study among primary care physicians in Hong Kong (Q31131825) (← links)
- Safety of human papillomavirus vaccines: a review. (Q33162724) (← links)
- Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials (Q33292779) (← links)
- Human Papillomavirus type distribution in invasive cervical cancer in Uganda (Q33346465) (← links)
- Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods (Q33382208) (← links)
- Nobel price for vaccination against cervical cancer: current data and guidelines (Q33433442) (← links)
- Warts (genital) (Q33448263) (← links)
- Genotype distribution of human papillomavirus (HPV) and co-infections in cervical cytologic specimens from two outpatient gynecological clinics in a region of southeast Spain (Q33491832) (← links)
- Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan (Q33523171) (← links)
- HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing country (Q33568522) (← links)
- Human papillomavirus vaccination in survivors of childhood cancer (Q33572460) (← links)
- Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women (Q33622107) (← links)
- DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women (Q33665786) (← links)
- HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities (Q33696724) (← links)
- Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK. (Q33708098) (← links)
- Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine (Q33723292) (← links)
- Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay (Q33723312) (← links)
- Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types (Q33774640) (← links)
- Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis (Q33791312) (← links)
- Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013. (Q33858092) (← links)
- Cost-effectiveness of different human papillomavirus vaccines in Singapore (Q33859018) (← links)
- Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus (Q33894441) (← links)
- Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds? (Q34029941) (← links)
- Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination (Q34033823) (← links)
- Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women (Q34038946) (← links)
- Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection (Q34054427) (← links)
- Integrating clinical, community, and policy perspectives on human papillomavirus vaccination (Q34078572) (← links)
- Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity. (Q34078674) (← links)
- Factors affecting transmission of mucosal human papillomavirus (Q34149651) (← links)
- HPV catch-up vaccination of young women: a systematic review and meta-analysis (Q34157209) (← links)
- Perspective for prophylaxis and treatment of cervical cancer: an immunological approach. (Q34181909) (← links)
- Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial (Q34199560) (← links)